We tested by in-house ELISA a previously identified positive serum for CUZD1 autoantibodies (positive serum), one negative serum and an additional two IBD patient sera (Serum #1 and Serum #2) which were highly positive for CUZD1 autoantibodies by immunofluorescence. This evidence concerns the gene CUZD1 and inflammatory bowel disease.